| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Hyeyoung Kim | |
| Min-Hyun Kim | |||
| P2860 | cites work | XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease | Q22252318 |
| Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis | Q24656576 | ||
| Glutamine as an immunonutrient | Q26853577 | ||
| Intestinal permeability regulation by tight junction: implication on inflammatory bowel diseases | Q26859272 | ||
| Have we enough glutamine and how does it work? A clinician's view | Q27009994 | ||
| Autophagy in the Pathogenesis of Disease | Q27860558 | ||
| Tight junction proteins | Q28217124 | ||
| Stem cells, self-renewal, and differentiation in the intestinal epithelium | Q28294807 | ||
| Regulation of cancer cell metabolism | Q28303890 | ||
| Activation of caspases in intestinal villus epithelial cells of normal and nematode infected rats | Q28344348 | ||
| Glutamine-mediated dual regulation of heat shock transcription factor-1 activation and expression | Q28582486 | ||
| Intestinal mucosal amino acid catabolism | Q28679241 | ||
| Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production | Q29614472 | ||
| A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 | Q29614873 | ||
| Growing roles for the mTOR pathway | Q29616212 | ||
| Caspase and bid involvement in Clostridium difficile toxin A-induced apoptosis and modulation of toxin A effects by glutamine and alanyl-glutamine in vivo and in vitro | Q30439015 | ||
| Glutamine: do the data support the cause for glutamine supplementation in humans? | Q31032277 | ||
| Effect of high-dose growth hormone and glutamine on body composition, urine creatinine excretion, fatty acid absorption, and essential fatty acids status in short bowel patients: a randomized, double-blind, crossover, placebo-controlled study | Q32059651 | ||
| Review: The role of glutathione in the regulation of apoptosis | Q33593239 | ||
| Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer | Q33604129 | ||
| Glutamine, as a precursor of glutathione, and oxidative stress | Q33651337 | ||
| Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice | Q33822567 | ||
| Apoptosis in the intestinal epithelium: its relevance in normal and pathophysiological conditions | Q33874214 | ||
| Metabolic response of muscle to alanine, glutamine, and valine supplementation during severe illness | Q44583156 | ||
| Glutamine and transforming growth factor-alpha stimulate extracellular regulated kinases and enhance recovery of villous surface area in porcine ischemic-injured intestine | Q44870903 | ||
| Glutamine regulates Caco-2 cell tight junction proteins | Q44886419 | ||
| L-Glutamine ameliorates acetaldehyde-induced increase in paracellular permeability in Caco-2 cell monolayer | Q45032126 | ||
| Amino acids suppress apoptosis induced by sodium laurate, an absorption enhancer. | Q45920868 | ||
| NF-κB is 25. | Q46097461 | ||
| Glutamine modulates CD8αα(+) TCRαβ(+) intestinal intraepithelial lymphocyte expression in mice with polymicrobial sepsis | Q46101914 | ||
| Effects of glutamine on proinflammatory gene expression and activation of nuclear factor kappa B and signal transducers and activators of transcription in TNBS-induced colitis | Q46486256 | ||
| Glutamine attenuates lung injury and improves survival after sepsis: role of enhanced heat shock protein expression | Q46533733 | ||
| Randomised trial of glutamine, selenium, or both, to supplement parenteral nutrition for critically ill patients | Q47590936 | ||
| L-Glutamine Enhances Tight Junction Integrity by Activating CaMK Kinase 2-AMP-Activated Protein Kinase Signaling in Intestinal Porcine Epithelial Cells. | Q53178021 | ||
| Glutamine modulates acute dextran sulphate sodium-induced changes in small-intestinal intraepithelial γδ-T-lymphocyte expression in mice. | Q54235824 | ||
| Modulation of glutamine metabolism by the PI(3)K-PKB-FOXO network regulates autophagy. | Q54495638 | ||
| Glutamine deprivation induces apoptosis in intestinal epithelial cells. | Q57773641 | ||
| Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF-κB activation | Q63609779 | ||
| Absorption and metabolic effects of enterally administered glutamine in humans | Q67988725 | ||
| L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta | Q68575443 | ||
| Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis | Q70539279 | ||
| Muscle and plasma amino acids following injury. Influence of intercurrent infection | Q71288582 | ||
| Parenteral nutrition is associated with intestinal morphologic and functional changes in humans | Q71369086 | ||
| Response of glutamine metabolism to exogenous glutamine in humans | Q71552988 | ||
| Gut adaptation and the insulin-like growth factor system: regulation by glutamine and IGF-I administration | Q71836477 | ||
| Apoptosis of crypt epithelial cells in ulcerative colitis | Q71928770 | ||
| Effect of growth hormone, glutamine, and diet on body composition in short bowel syndrome: a randomized, controlled study | Q73211011 | ||
| L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases | Q73399527 | ||
| Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition | Q73403151 | ||
| Effects of an isotonic oral rehydration solution, enriched with glutamine, on fluid and sodium absorption in patients with a short-bowel | Q73716968 | ||
| Effect of growth hormone, glutamine, and diet on adaptation in short-bowel syndrome: a randomized, controlled study | Q73760524 | ||
| Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation | Q73847660 | ||
| Enteral versus parenteral nutrition | Q74260915 | ||
| A double-blind placebo-controlled pilot study of glutamine therapy for abnormal intestinal permeability in patients with AIDS | Q74730531 | ||
| Dietary glutamine supplementation reduces plasma nitrate levels in rats | Q77330866 | ||
| Heat shock inhibits activation of NF-kappaB in the absence of heat shock factor-1 | Q77663433 | ||
| Effect of long-term oral glutamine supplements on small intestinal permeability in patients with Crohn's disease | Q77794423 | ||
| Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation? | Q79320465 | ||
| Glutamine and the immune system | Q79913486 | ||
| Glutamine metabolism by lymphocytes, macrophages, and neutrophils: its importance in health and disease | Q80991633 | ||
| Protein kinase C enhances tight junction barrier function of human nasal epithelial cells in primary culture by transcriptional regulation | Q81269869 | ||
| Route of administration (enteral or parenteral) affects the contribution of L-glutamine to de novo L-arginine synthesis in mice: a stable-isotope study | Q83309995 | ||
| Glutamine therapy improves outcome of in vitro and in vivo experimental colitis models | Q83540697 | ||
| Glutamine modulates sepsis-induced changes to intestinal intraepithelial γδT lymphocyte expression in mice | Q84551569 | ||
| Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium | Q84676732 | ||
| The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine | Q33882001 | ||
| Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease | Q33886201 | ||
| Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? | Q33954365 | ||
| Regulative potential of glutamine--relation to glutathione metabolism. | Q33957782 | ||
| Nitric oxide and intestinal inflammation | Q34019768 | ||
| The Stat family in cytokine signaling | Q34180677 | ||
| Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial | Q34228766 | ||
| Heat shock proteins: endogenous modulators of apoptotic cell death | Q34340472 | ||
| Nitric oxide in immunity and inflammation | Q34342605 | ||
| Glutamine metabolism in sepsis and infection | Q34353985 | ||
| Intestinal inflammation and mucosal barrier function | Q34438743 | ||
| Glutamine treatment attenuates endoplasmic reticulum stress and apoptosis in TNBS-induced colitis | Q34500273 | ||
| Glutamine and heat shock protein expression | Q34554295 | ||
| Glutamine and its relationship with intracellular redox status, oxidative stress and cell proliferation/death | Q34572853 | ||
| MAPK signal pathways in the regulation of cell proliferation in mammalian cells | Q34593370 | ||
| Glutamine supplementation in serious illness: a systematic review of the evidence | Q34916175 | ||
| Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. | Q35083579 | ||
| Clinical evidence for enteral nutritional support with glutamine: a systematic review | Q35201118 | ||
| Intestinal fuels: glutamine, short-chain fatty acids, and dietary fiber | Q35234085 | ||
| Effect of high dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: a randomised, double blind, crossover, placebo controlled study | Q35360775 | ||
| Glutamine: metabolism and application in nutrition support. | Q35683679 | ||
| Regulation of tight junctions and loss of barrier function in pathophysiology | Q35756449 | ||
| Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis | Q35841124 | ||
| Gastrointestinal stem cells. II. Intestinal stem cells | Q36225076 | ||
| Caspase family proteases and apoptosis | Q36306299 | ||
| Molecular mechanisms contributing to glutamine-mediated intestinal cell survival | Q36728699 | ||
| Glutamine: mode of action in critical illness | Q36916515 | ||
| Exogenous glutamine: the clinical evidence | Q36916518 | ||
| Crosstalk of tight junction components with signaling pathways | Q36976365 | ||
| Myosin light chain kinase signaling in endothelial barrier dysfunction | Q37076073 | ||
| Glutamine increases autophagy under Basal and stressed conditions in intestinal epithelial cells | Q37171062 | ||
| Glutamine, arginine, and leucine signaling in the intestine | Q37364534 | ||
| Apoptosis of human intestinal epithelial cells after bacterial invasion | Q37387961 | ||
| Effects of dietary glutamine on the homeostasis of CD4+ T cells in mice with dextran sulfate sodium-induced acute colitis | Q37458560 | ||
| Vascular endothelial tight junctions and barrier function are disrupted by 15(S)-hydroxyeicosatetraenoic acid partly via protein kinase C ε-mediated zona occludens-1 phosphorylation at threonine 770/772. | Q37563388 | ||
| Is glutamine a conditionally essential amino acid? | Q37783687 | ||
| Intestinal inflammation and cancer | Q37870432 | ||
| A review of the role of acid-base balance in amino acid nutrition | Q37906136 | ||
| Roles of glutamine in neurotransmission. | Q37948212 | ||
| Autophagy and intestinal homeostasis | Q38065286 | ||
| Metabolic regulation of immune responses | Q38198155 | ||
| Glutamine and intestinal barrier function | Q38223273 | ||
| Oncogenes and tumor suppressors regulate glutamine metabolism in cancer cells | Q38261953 | ||
| Mechanism of glutamine-mediated amelioration of lipopolysaccharide-induced IL-8 production in Caco-2 cells | Q38343072 | ||
| Is insulin-like growth factor 1 (IGF-1) system an attractive target inflammatory bowel diseases? Benefits and limitation of potential therapy | Q38818356 | ||
| Tight junctions: from simple barriers to multifunctional molecular gates | Q38879992 | ||
| Celiac Disease: Role of the Epithelial Barrier | Q38919389 | ||
| Cytokines in inflammatory bowel disease | Q39206254 | ||
| L-Glutamine or L-alanyl-L-glutamine prevents oxidant- or endotoxin-induced death of neonatal enterocytes | Q39888150 | ||
| Tight junctions and the molecular basis for regulation of paracellular permeability | Q40373935 | ||
| Anti-apoptotic effects of L-glutamine-mediated transcriptional modulation of the heat shock protein 72 during heat shock | Q40398361 | ||
| Glutamine modulates LPS-induced IL-8 production through IkappaB/NF-kappaB in human fetal and adult intestinal epithelium. | Q40465533 | ||
| Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist | Q40945812 | ||
| Possible involvement of phosphorylation of occludin in tight junction formation | Q41104367 | ||
| Oral glutamine reduces bacterial translocation following abdominal radiation | Q41222683 | ||
| STAT signaling in inflammation | Q41392782 | ||
| CK2-dependent phosphorylation of occludin regulates the interaction with ZO-proteins and tight junction integrity. | Q41506361 | ||
| Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. | Q41540354 | ||
| Glutamine and nucleotide metabolism within enterocytes | Q41732344 | ||
| Molecular architecture of tight junctions | Q41748256 | ||
| A common role for Atg16L1, Atg5 and Atg7 in small intestinal Paneth cells and Crohn disease | Q41904813 | ||
| MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide | Q41964987 | ||
| Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells | Q42251542 | ||
| A randomized trial of glutamine and antioxidants in critically ill patients | Q42266312 | ||
| Glutamine and barrier function in cultured Caco-2 epithelial cell monolayers | Q42444147 | ||
| Glutamine pretreatment reduces IL-8 production in human intestinal epithelial cells by limiting IkappaBalpha ubiquitination | Q42495415 | ||
| Parenteral L-alanyl-L-glutamine improves 6-month outcome in critically ill patients | Q42684404 | ||
| Quantitative aspects of glucose and glutamine metabolism by intestinal cells | Q43218755 | ||
| Plasma glutamine depletion and patient outcome in acute ICU admissions | Q43561049 | ||
| Effect of glutamine in short-bowel syndrome | Q43691523 | ||
| Infection, multiple organ failure, and survival in the intensive care unit: influence of glutamine-supplemented parenteral nutrition on acquired infection | Q44047192 | ||
| Glutamine and arginine improve permeability and tight junction protein expression in methotrexate-treated Caco-2 cells | Q44427054 | ||
| P275 | copyright license | Creative Commons Attribution | Q6905323 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human digestive system | Q9649 |
| amino acid | Q8066 | ||
| inflammatory bowel diseases | Q917447 | ||
| tissue | Q40397 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P577 | publication date | 2017-05-12 | |
| P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
| P1476 | title | The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases | |
| P478 | volume | 18 |
| Q92155459 | A Review of the Immunomodulating Components of Maternal Breast Milk and Protection Against Necrotizing Enterocolitis |
| Q89592138 | A free amino acid-based diet partially prevents symptoms of cow's milk allergy in mice after oral sensitization with whey |
| Q88924058 | Combination of arginine, glutamine, and omega-3 fatty acid supplements for perioperative enteral nutrition in surgical patients with gastric adenocarcinoma or gastrointestinal stromal tumor (GIST): A prospective, randomized, double-blind study |
| Q92819926 | Dietary intake from complementary feeding is associated with intestinal barrier function and environmental enteropathy in Brazilian children from the MAL-ED cohort study |
| Q94552003 | Effect of Berberine from Coptis chinensis on Apoptosis of Intestinal Epithelial Cells in a Mouse Model of Ulcerative Colitis: Role of Endoplasmic Reticulum Stress |
| Q93107494 | Effects of Early Enteral Glutamine Supplementation on Intestinal Permeability in Critically Ill Patients |
| Q89884839 | Effects of dietary valine supplementation during late gestation on the reproductive performance and mammary gland development of gilts |
| Q54114870 | Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation. |
| Q58605197 | Gamma-Glutamyltranspeptidase Expression by Helicobacter saguini, an Enterohepatic Helicobacter Species Isolated from Cotton Top Tamarins with Chronic Colitis |
| Q92645817 | Glutamine protects intestinal mucosa and promotes its transport after burn injury in rats |
| Q56561451 | Glutamine supplementation improves intestinal cell proliferation and stem cell differentiation in weanling mice |
| Q58576996 | Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation |
| Q90020419 | Gut-origin sepsis in the critically ill patient: pathophysiology and treatment |
| Q92535923 | Heat Adaptation in Military Personnel: Mitigating Risk, Maximizing Performance |
| Q92703288 | Influence of Growth Hormone and Glutamine on Intestinal Stem Cells: A Narrative Review |
| Q97518928 | Intestinal Ca2+ absorption revisited: A molecular and clinical approach |
| Q90260632 | Mechanisms of Regulation of Transporters of Amino Acid Absorption in Inflammatory Bowel Diseases |
| Q54985437 | Metabolic Adaptations of CD4+ T Cells in Inflammatory Disease. |
| Q91878778 | Metabolic maturation in the first 2 years of life in resource-constrained settings and its association with postnatal growths |
| Q92155682 | Mutual Interactions among Exercise, Sport Supplements and Microbiota |
| Q92445830 | Neutrophil Metabolic Shift during their Lifecycle: Impact on their Survival and Activation |
| Q89835092 | Nutrition in Necrotizing Enterocolitis and Following Intestinal Resection |
| Q92066026 | Performance, intestinal permeability, and gene expression of selected tight junction proteins in broiler chickens fed reduced protein diets supplemented with arginine, glutamine, and glycine subjected to a leaky gut model |
| Q92059457 | Possible role of intestinal stem cells in the pathophysiology of irritable bowel syndrome |
| Q92704649 | Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation |
| Q91942029 | Protective Effects Oncorneal Endothelium During Intracameral Irrigation Using N-(2)-l-alanyl-l-Glutamine |
| Q97532217 | Strategies and recommendations for the management of gastrointestinal surgery during the COVID-19 pandemic: experience shared by Chinese surgeons |
| Q64237577 | The 'Achilles Heel' of Metabolism in Renal Cell Carcinoma: Glutaminase Inhibition as a Rational Treatment Strategy |
| Q89860671 | The Gastrointestinal Exertional Heat Stroke Paradigm: Pathophysiology, Assessment, Severity, Aetiology and Nutritional Countermeasures |
| Q59327092 | The Glutaminase-Dependent Acid Resistance System: Qualitative and Quantitative Assays and Analysis of Its Distribution in Enteric Bacteria |
| Q64108070 | The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids |
| Q64290756 | Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma |
| Q92611006 | Using Twitter to Understand the Human Bowel Disease Community: Exploratory Analysis of Key Topics |
| Q98652622 | α-Ketoglutarate attenuates Wnt signaling and drives differentiation in colorectal cancer |
Search more.